Edwards Lifesciences Executive and Leadership Team

Gerianne Sarte, the Senior Vice President, Business Unit Chief Financial Officer - Surgical at Edwards Lifesciences, directs financial strategy and operations for the surgical business unit. This leadership position involves overseeing all financial planning, analysis, and reporting activities critical to the unit's performance and growth. Sarte ensures robust financial controls and drives fiscal discipline across the surgical segment, aligning financial objectives with the company's broader mission of improving patient outcomes. The role demands a deep understanding of the medical technology market and the specific financial dynamics of structural heart disease solutions. Gerianne Sarte's oversight extends to managing budgets, forecasting revenue, and identifying investment opportunities that support innovation and market expansion within the surgical domain. This executive's financial acumen is vital for sustaining the company's commitment to delivering life-changing therapies and maintaining its leadership in cardiovascular care.

Hassan Gawuna, the Deputy Chief Financial Officer at Edwards Lifesciences, supports the Chief Financial Officer in managing the company's overall financial health and strategic fiscal direction. Gawuna's responsibilities encompass a broad range of financial activities, including capital allocation, financial risk management, and the development of long-term financial plans. This role is integral to ensuring the company's financial stability and capacity for continued investment in groundbreaking medical technologies. Hassan Gawuna collaborates closely with various departments to optimize financial performance and resource utilization across global operations. The Deputy Chief Financial Officer plays a key part in financial reporting, compliance, and investor relations, ensuring transparency and accountability. By driving efficient financial processes, Gawuna contributes directly to Edwards Lifesciences' ability to deliver innovative solutions for structural heart disease and critical care monitoring, ultimately supporting the mission to improve patient lives worldwide.

Miyuki Ogushi, the Representative Executive Officer and President and at Edwards Lifesciences, holds a pivotal leadership position driving the company's strategic vision and operational execution. This executive role involves overseeing broad corporate initiatives and ensuring alignment across all business functions to achieve the company's mission of improving patient outcomes. Ogushi's leadership guides the development and deployment of innovative solutions for structural heart disease and critical care monitoring. The responsibilities include fostering a culture of innovation, managing key stakeholder relationships, and steering the company through evolving market landscapes. Miyuki Ogushi's executive decisions are critical for advancing life-changing therapies and maintaining Edwards Lifesciences' global leadership in cardiovascular care. This position requires a comprehensive understanding of the medical technology sector and a commitment to advancing patient well-being through cutting-edge advancements.

Joseph Nuzzolese, the Corporate Vice President, Global Supply Chain & Quality at Edwards Lifesciences, directs the intricate network of global supply chain operations and ensures the highest standards of quality across all products. Nuzzolese's leadership is fundamental to the reliable delivery of life-changing therapies for structural heart disease and critical care monitoring. This executive oversees procurement, logistics, manufacturing support, and quality assurance systems, ensuring seamless integration and adherence to stringent regulatory requirements. Joseph Nuzzolese's strategic focus on supply chain optimization and quality management directly impacts patient safety and the company's ability to meet global demand. By maintaining robust quality control processes and efficient supply chain logistics, Nuzzolese supports Edwards Lifesciences' mission to improve patient outcomes and advance cardiovascular care through innovative medical technologies.

Daveen Chopra, the Corporate Vice President, Surgical Structural Heart at Edwards Lifesciences, spearheads the strategic direction and commercial execution for the surgical structural heart business. Chopra's leadership drives the advancement and market penetration of innovative therapies designed to treat complex cardiovascular conditions. This role involves close collaboration with R&D, clinical affairs, and sales teams to ensure the successful development and launch of new technologies. Daveen Chopra's focus is on expanding access to life-changing treatments for patients suffering from structural heart disease, reinforcing Edwards Lifesciences' commitment to improving patient outcomes. The executive oversees market analysis, product lifecycle management, and the cultivation of strong relationships with healthcare professionals globally. Chopra's strategic insights are crucial for maintaining the company's competitive edge and leadership in the surgical structural heart segment.

Donald Bobo, the Corporate Vice President, Strategy & Corporate Development at Edwards Lifesciences, architects the company's long-term strategic planning and identifies key opportunities for corporate development and expansion. Bobo's role is critical in shaping the future direction of Edwards Lifesciences, focusing on initiatives that enhance its leadership in structural heart disease and critical care monitoring. This executive leads efforts in mergers, acquisitions, partnerships, and strategic alliances that align with the company's mission to improve patient outcomes. Donald Bobo evaluates market trends, competitive landscapes, and emerging technologies to ensure sustained growth and innovation. The strategic vision developed under Bobo's guidance supports the continuous delivery of life-changing therapies and reinforces the company's commitment to advancing cardiovascular care through cutting-edge medical technologies.